Anticancer drug may improve outcome for severe COVID-19 patients
Date Time Anticancer drug may improve outcome for severe COVID-19 patients Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published in Nature Communications. Yihai Cao, photo: Ulf Si...
Source: miragenews.com